drugset / Trial / NCT05546658

Effects of Psilocybin in Obsessive Compulsive Disorder

NCT05546658

Phase 0 Active not recruiting 35 enrolled Johns Hopkins University Usona Institute · collab
RandomizedCrossoverOpen-labelTreatment

Summary

This study will test the feasibility, safety, and evidence for efficacy of psilocybin administration in participants with obsessive compulsive disorder (OCD). This will serve as a preliminary proof of concept study for future larger studies aimed to investigate the utility, cognitive mechanisms, and neural correlates of this intervention.

Timeline

Start
2022-11-28
Primary completion
2026-09-12
Completion
2027-09-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Psilocybin Other / unclassified 30 mg